Gian Life Care P/E Ratio
Gian Life Care P/E ratio. Gian Life Care (GIANLIFE) P/E ratio is not applicable — EPS (TTM) ₹-0.04, 2 consecutive loss quarters. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 2 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 2
Current EPS: ₹-0.04
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.50 | -1 | Loss |
| Mar 2025 | -0.59 | -1 | Loss |
| Jun 2025 | 0.05 | 0 | Profit |
| Dec 2025 | 0.10 | 0 | Profit |
| Sept 2024 | 0.12 | 0 | Profit |
| Mar 2024 | 2.07 | 2 | Profit |
| Jun 2024 | 0.09 | 0 | Profit |
| Dec 2024 | 0.34 | 0 | Profit |
Healthcare Services Peers with Valid P/E Ratios — GIANLIFE Comparison
Healthcare Services sector average P/E 90.98, median 42.42 — GIANLIFE excluded (negative EPS).
Sector Average PE
90.98
Sector Median PE
42.42
Lowest PE
6.89
Profitable Companies
58
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.89 | ₹132 | Low |
| Abate AS Industries | ABATEAS | 9.74 | ₹115 | Low |
| Deccan Health Care | DECCAN | 12.41 | ₹32 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.45 | ₹19 | Low |
| Shanmuga Hospital | SHANMUGA | 14.41 | ₹61 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.49 | ₹1,074 | Low |
| Indraprastha Medical Cor… | INDRAMEDCO | 15.61 | ₹2,891 | Moderate |
| Invicta Diagnostic | INVICTA | 16.62 | ₹81 | Moderate |
| Clinitech Laboratory | CTLLAB | 17.58 | ₹7 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 17.74 | ₹1,728 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see GIANLIFE screener.
- Examine GIANLIFE earnings report for recent quarterly revenue, profit and EPS trends.
- Also explore Gian Life Care stock price data download to track price trends across different timeframes.